We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,863
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSBC icon
3976
Five Star Bancorp
FSBC
$1.15B
$13K ﹤0.01%
470
+98
+26% +$2.96K
GLDD
3977
DELISTED
Great Lakes Dredge & Dock
GLDD
$13K ﹤0.01%
960
-49
-5% -$705
HOOK
3978
DELISTED
HOOKIPA Pharma
HOOK
$13K ﹤0.01%
536
-1,397
-72% -$25K
HONE
3979
DELISTED
HarborOne Bancorp
HONE
$13K ﹤0.01%
947
-343
-27% -$5.03K
ICHR icon
3980
Ichor Holdings
ICHR
$2.66B
$13K ﹤0.01%
350
+150
+75% +$5.84K
IIIN icon
3981
Insteel Industries
IIIN
$631M
$13K ﹤0.01%
336
-240
-42% -$9.3K
INSW icon
3982
International Seaways
INSW
$4.81B
$13K ﹤0.01%
681
-341
-33% -$5.53K
LCUT icon
3983
Lifetime Brands
LCUT
$226M
$13K ﹤0.01%
1,028
-726
-41% -$10.1K
NGNE icon
3984
Neurogene
NGNE
$723M
$13K ﹤0.01%
348
-9
-3% -$525
NIC icon
3985
Nicolet Bankshares
NIC
$3.75B
$13K ﹤0.01%
142
-68
-32% -$6.34K
NNDM
3986
Nano Dimension
NNDM
$344M
$13K ﹤0.01%
3,789
-1,459
-28% -$5.26K
NPCE icon
3987
Neuropace
NPCE
$507M
$13K ﹤0.01%
1,632
+506
+45% +$4.37K
NRXP icon
3988
NRX Pharmaceuticals
NRXP
$140M
$13K ﹤0.01%
513
+491
+2,232% +$16K
NVCT icon
3989
Nuvectis Pharma
NVCT
$618M
$13K ﹤0.01%
+1,750
New +$12.2K
ONTF
3990
DELISTED
ON24
ONTF
$13K ﹤0.01%
945
+365
+63% +$5.49K
OVID icon
3991
Ovid Therapeutics
OVID
$553M
$13K ﹤0.01%
3,993
+212
+6% +$667
PLMR icon
3992
Palomar
PLMR
$3.37B
$13K ﹤0.01%
204
-1,507
-88% -$85.6K
PLSE icon
3993
Pulse Biosciences
PLSE
$3.18B
$13K ﹤0.01%
2,630
+1,551
+144% +$12.7K
PRO
3994
DELISTED
PROS Holdings
PRO
$13K ﹤0.01%
400
-2,843
-88% -$87.4K
QTRX icon
3995
Quanterix
QTRX
$122M
$13K ﹤0.01%
452
-678
-60% -$20.7K
RTB
3996
RTB Digital
RTB
$237M
$13K ﹤0.01%
9
-22
-71% -$27.5K
RXST icon
3997
RxSight
RXST
$287M
$13K ﹤0.01%
1,028
-982
-49% -$11.8K
SERA icon
3998
Sera Prognostics
SERA
$77.3M
$13K ﹤0.01%
3,519
+2,161
+159% +$12.5K
SOPA
3999
DELISTED
Society Pass
SOPA
$13K ﹤0.01%
285
+81
+40% +$5.2K
CNTN
4000
Canton Strategic Holdings
CNTN
$156M
$13K ﹤0.01%
+22
New +$20.7K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,863 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.